* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, October 6, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

    Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

    Why Taylor Swift Name-Dropped Elizabeth Taylor in Her New Album – Yahoo

    Here’s Why Taylor Swift Dropped Elizabeth Taylor’s Name in Her New Album

    Al Roker Gives Olivia Dean an Unexpected ‘New Job’ on the ‘Today’ Show – Yahoo

    Al Roker Shocks Olivia Dean with an Exciting New Role on the ‘Today’ Show

    Books about the arts and some haunts for a Denton October – Denton Record-Chronicle

    Uncover Artistic Treasures and Spooky Adventures to Experience in Denton This October

    Taylor Swift Releases New Album The Life of a Showgirl : Listen and Read the Full Credits – Yahoo

    Taylor Swift Releases New Album The Life of a Showgirl : Listen and Read the Full Credits – Yahoo

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Forget Cowbells. Cows Wear High-Tech Collars Now. – The New York Times

    Ditch the Cowbells: Discover the High-Tech Collars Transforming Cattle Care

    What the Recent Price Surge Means for Figure Technology Solutions After SEC Settlement – Yahoo Finance

    What the Recent Price Surge Reveals About Figure Technology Solutions Following SEC Settlement

    MAC Brings iPad Technology to Football Sidelines Across All 13 Member Schools – Sports Video Group

    MAC Brings iPad Technology to Football Sidelines Across All 13 Member Schools – Sports Video Group

    Technology Is Becoming More Important Than Humans In CX – No Jitter

    Technology Is Becoming More Important Than Humans In CX – No Jitter

    A Tech Expo Shows What China Can Make, but Not Who’ll Buy It All – The New York Times

    Inside China’s Tech Expo: Cutting-Edge Innovations Face Uncertain Demand

    Steampunk Metal Oval Technology Sense Sunglasses Personality Handmade Chain Multicolor Sunglasses UV400 – The San Joaquin Valley Sun

    Steampunk Metal Oval Sunglasses with Handmade Multicolor Chain – Bold UV400 Protection and Unique Style

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

    Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

    Why Taylor Swift Name-Dropped Elizabeth Taylor in Her New Album – Yahoo

    Here’s Why Taylor Swift Dropped Elizabeth Taylor’s Name in Her New Album

    Al Roker Gives Olivia Dean an Unexpected ‘New Job’ on the ‘Today’ Show – Yahoo

    Al Roker Shocks Olivia Dean with an Exciting New Role on the ‘Today’ Show

    Books about the arts and some haunts for a Denton October – Denton Record-Chronicle

    Uncover Artistic Treasures and Spooky Adventures to Experience in Denton This October

    Taylor Swift Releases New Album The Life of a Showgirl : Listen and Read the Full Credits – Yahoo

    Taylor Swift Releases New Album The Life of a Showgirl : Listen and Read the Full Credits – Yahoo

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Forget Cowbells. Cows Wear High-Tech Collars Now. – The New York Times

    Ditch the Cowbells: Discover the High-Tech Collars Transforming Cattle Care

    What the Recent Price Surge Means for Figure Technology Solutions After SEC Settlement – Yahoo Finance

    What the Recent Price Surge Reveals About Figure Technology Solutions Following SEC Settlement

    MAC Brings iPad Technology to Football Sidelines Across All 13 Member Schools – Sports Video Group

    MAC Brings iPad Technology to Football Sidelines Across All 13 Member Schools – Sports Video Group

    Technology Is Becoming More Important Than Humans In CX – No Jitter

    Technology Is Becoming More Important Than Humans In CX – No Jitter

    A Tech Expo Shows What China Can Make, but Not Who’ll Buy It All – The New York Times

    Inside China’s Tech Expo: Cutting-Edge Innovations Face Uncertain Demand

    Steampunk Metal Oval Technology Sense Sunglasses Personality Handmade Chain Multicolor Sunglasses UV400 – The San Joaquin Valley Sun

    Steampunk Metal Oval Sunglasses with Handmade Multicolor Chain – Bold UV400 Protection and Unique Style

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Type 2 Diabetes Drug Class Could Benefit Teens With Type 1

June 28, 2024
in Health
Type 2 Diabetes Drug Class Could Benefit Teens With Type 1
Share on FacebookShare on Twitter

ORLANDO, Florida — A low dose of the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin combined with insulin improved glycemic control and slowed kidney function decline in adolescents with type 1 diabetes, new trial results showed. 

Diabetic ketoacidosis (DKA), an ongoing concern with the SGLT2i class, occurred in only one participant taking the drug in the ATTEMPT trial although significantly more experienced blood ketones with dapagliflozin than with placebo. The data were presented June 24, 2024, in a 90-minute symposium at the annual American Diabetes Association Scientific Sessions. 

Currently, the SGLT2i drug class is not approved by the US Food and Drug Administration for use in people with type 1 diabetes.

Adolescents with type 1 diabetes were studied in ATTEMPT because 75% don’t meet glycemic goals, and many develop supraphysiologic increases in glomerular filtration rate, or hyperfiltration. Prevention of kidney disease progression is important because chronic kidney disease is seen in half of adults with type 1 diabetes, lead investigator Farid Mahmud, MD, a pediatric endocrinologist at the University of Toronto, Toronto, Ontario, Canada, explained at a press briefing held during the meeting. 

The ATTEMPT trial showed that “low-dose SGL2i, in this case dapagliflozin 5 mg, can be safely given to adolescents and youth with type 1 diabetes to ameliorate kidney function decline and optimize glycemic control,” Mahmud said. 

Importantly, he noted that the study included a DKA mitigation strategy developed in conjunction with patients. “This allows us a really important framework for how we evaluate important physiologic outcomes, metabolic outcomes, and clinically relevant outcomes in a patient-centered way when we look at adjunctive therapies in addition to insulin to optimize management in youth with type 1 diabetes.”

Pediatric endocrinologist Jennifer Sherr, MD, PhD, professor of pediatrics at Yale University, New Haven, Connecticut, told Medscape Medical News, “It’s hard in the real world, because you may not have the same amount of time, or you may not have the same refined DKA mitigation plan. But, I think what we’re on the precipice of having new tools. If we can have continuous ketone monitors, which I think is in the not-too-distant future, it opens everything up.”

Added Sherr, who gave independent commentary during the conference symposium, “The way I look at it, these kids had a lifetime of diabetes…I want them to lead long and healthy lives…Who knows if [the improvement in kidney function] is because of the drop in [glomerular filtration rate] or the improved glucose levels, or a multitude of things coming together. But if we can help protect them, I think that with integration of a continuous ketone monitor I can see it becoming much more prevalent.”

With Mitigation Strategy, Only One Mild Case of DKA

In the multicenter, double-blinded, randomized, placebo-controlled ATTEMPT trial, 98 youth with type 1 diabetes aged 12-18 years were randomized to either 5 mg per day of dapagliflozin or placebo for 22 weeks. 

The group receiving dapagliflozin experienced a significant attenuation in the direct evaluation of the “good standard” measured glomerular filtration rate. A1c also declined significantly, by 0.48 percentage points (P=.001). 

There were no significant differences in the occurrence of adverse events overall or in hypoglycemia or genitourinary tract infections. While not statistically significant, there was one mild case of DKA with dapagliflozin. Moreover, the dapagliflozin group also had a significantly greater number of blood ketone levels at or above 6 mmol/L, 106 vs 62 with placebo (P <.001 see ketosis in both groups because these individuals have type diabetes mahmud commented.>

Sherr commented, “I was so grateful they did the study in such a planned, cautious manner and had the right systems built in to show this can be done safely. I think they laid the groundwork to say this can be done in theory. And I do think it’ll be select groups at first, but then it will go to larger groups, and with better tools, even larger.”

Mahmud told Medscape Medical News, “How do we mitigate risk in people who don’t have symptoms, kidney disease, or cardiovascular disease? We have to think of who the child may become. That’s important for us to do as pediatricians.” 

Will SGLT2 Inhibitors Become Available for People With Type 1 Diabetes?

The presentation of the ATTEMPT findings at ADA came just 3 days after an announcement by Lexicon Pharmaceuticals stating it resubmitted its New Drug Application for its dual SGLT1/SGLT2 inhibitor sotagliflozin as an adjunct to insulin therapy for glycemic control in people with type 1 diabetes and chronic kidney disease. 

The FDA had previously rejected sotagliflozin as adjunctive treatment for type 1 diabetes in March 2019 and subsequently also rejected dapagliflozin and empagliflozin as well for type 1 diabetes. The focus on individuals with kidney disease is new.

The ATTEMPT Study was supported by JDRF Canada in partnership with the Canadian Institute of Health Research, Strategies for Patient Oriented Research. AstraZeneca donated the drug, and Dexcom, the continuous glucose sensors, used in the trial. Mahmud had no further disclosures. Sherr received grants/contracts, consulting/advisory board fees, and/or payment/honoraria from JDRF, National Institute of Diabetes and Digestive and Kidney Diseases, Jaeb Center for Health Research, Insulet, Medtronic, Provention Bio, Abbott, Medtronic Diabetes, Zealand Pharma, Bigfoot Medical, Cecelia Health, Novo Nordisk, and Vertex Pharmaceuticals. She also reported owning stock/stock options of StartUp Health T1D Moonshot. 

Miriam E. Tucker is a freelance journalist based in the Washington DC area. She is a regular contributor to Medscape Medical News, with other work appearing in the Washington Post, NPR’s Shots blog, and Diatribe. She is on X @MiriamETucker.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/type-2-diabetes-drug-class-could-benefit-teens-type-1-2024a1000c0r

Tags: classdiabeteshealth
Previous Post

Rural Hospital Closures Harm Local Real Estate

Next Post

Two-Drug Combo Promising for Methamphetamine Use Disorder

Air quality speed run – Washington State Department of Ecology (.gov)

Race Against Pollution: Washington State’s Air Quality Challenge

October 6, 2025
Equity in science is a beautiful lie — and I’m done pretending – Nature

Equity in science is a beautiful lie — and I’m done pretending – Nature

October 6, 2025
Explore a bird database with 11,500 species – Popular Science

Explore an Incredible Bird Database Showcasing 11,500 Stunning Species

October 6, 2025
South Shore broker funded ‘extravagant lifestyle’ with $11.6 million taken from clients and colleagues, prosecutors say – Boston.com

South Shore broker funded ‘extravagant lifestyle’ with $11.6 million taken from clients and colleagues, prosecutors say – Boston.com

October 6, 2025
QRG Capital Management Inc. Purchases 9,519 Shares of Marvell Technology, Inc. $MRVL – MarketBeat

QRG Capital Management Takes Bold Step by Acquiring 9,519 Shares of Marvell Technology

October 6, 2025
Jaxson Dart, Cam Skattebo fumble away a Giant opportunity vs. Saints – Yahoo Sports

Jaxson Dart, Cam Skattebo fumble away a Giant opportunity vs. Saints – Yahoo Sports

October 6, 2025
‘The World Report’ of The Church of Jesus Christ of Latter-day Saints – KSL TV 5

Inside The World Report: Exploring the Impact of The Church of Jesus Christ of Latter-day Saints

October 6, 2025
Thai Airways Launches New Premium Economy on Flights From Most Visited City in the World – Aviation A2Z

Thai Airways Launches New Premium Economy on Flights From Most Visited City in the World – Aviation A2Z

October 6, 2025
Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

October 6, 2025
Pre-rolls, education and industry optimism: Takeaways from Ohio Cannabis Health & Business Summit 2025 – Cleveland.com

Pre-rolls, Education, and Industry Optimism: Top Insights from the Ohio Cannabis Health & Business Summit 2025

October 6, 2025

Categories

Archives

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (854)
  • Economy (874)
  • Entertainment (21,748)
  • General (17,441)
  • Health (9,916)
  • Lifestyle (887)
  • News (22,149)
  • People (876)
  • Politics (885)
  • Science (16,085)
  • Sports (21,375)
  • Technology (15,855)
  • World (857)

Recent News

Air quality speed run – Washington State Department of Ecology (.gov)

Race Against Pollution: Washington State’s Air Quality Challenge

October 6, 2025
Equity in science is a beautiful lie — and I’m done pretending – Nature

Equity in science is a beautiful lie — and I’m done pretending – Nature

October 6, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version